Kaplan Fox Encourages Investors of Gildan Activewear Inc. (NYSE: GIL) to Contact the Firm to Learn About Their Legal Rights

Gildan shares fell $11.63, or 18.7%, to close at $50.34 on June 16, 2026, after short seller Jehoshaphat Research published allegations of channel stuffing and roughly $500 million in revenue pulled forward. A class action lawsuit now alleges that Gildan lacked adequate internal controls and used channel stuffing to create an appearance of revenue; these are allegations, not established findings. Investors in the proposed class have until December 14, 2026, to seek lead-plaintiff status.

Analysis

The key risk is not the class-action filing itself, but whether the allegations become testable in the accounts: rising receivables relative to sales, weaker cash conversion, unusual quarter-end shipments, subsequent returns, or revisions to prior-period revenue. The cited research came from a disclosed short seller; neither the report nor the complaint establishes that the accounting allegations are true. A procedural lead-plaintiff deadline is not a merits catalyst, and the reported June selloff means the initial shock is already in the price.

Near term, expect headline-driven volatility rather than a clean litigation repricing. Over the next 1–3 months, monitor Gildan’s filings, auditor commentary, collections and any company response; credible evidence of channel loading could pressure revenue quality and valuation beyond the direct legal exposure. Over 6–18 months, confirmed control weaknesses or restatements could raise financing and governance concerns and reduce confidence in reported growth. Conversely, clean subsequent cash collections and stable disclosures would weaken the short thesis. Competitors such as Hanesbrands could see relative investor attention, but there is no basis here to infer they benefit operationally or share the alleged practices. The contrarian point: litigation headlines can keep risk premia elevated even without proof, but an aggressive short after a large prior repricing risks a squeeze if allegations fail to gain corroboration.

Key Decisions for Investors

• Do not treat the complaint as independent confirmation of channel stuffing; distinguish the short-seller allegations from verified accounting evidence.
• For existing GIL exposure, review position sizing against downside from a revenue-quality issue and monitor receivables, cash conversion, returns, auditor language and any restatement or guidance change.
• No fresh outright short is justified from this filing alone. Consider a defined-risk put spread only if upcoming disclosures corroborate the allegations; avoid paying for event volatility without a dated, substantive catalyst.
• Set a thesis-falsification checklist: improving collections and cash conversion, no material revenue revisions, and credible control disclosures would argue against the bearish case; adverse auditor findings, restatements or deteriorating receivables would strengthen it.